Steven Cohen’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Steven Cohen's VRTX Position: Q3 2026 in Review
Steven Cohen sold out of Vertex Pharmaceuticals (VRTX) in Q3 2026, closing a stake of 2,625 shares — an estimated $1.34M sold.
Steven Cohen first reported a position in VRTX in Q2 2014 and held it in 30 quarters. The position peaked at $143M in Q1 2021. 1,797 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Steven Cohen reported no remaining Vertex Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- Steven Cohen sold 2,625 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.34M.
- Steven Cohen first reported a position in Vertex Pharmaceuticals in Q2 2014 and held it in 30 quarters.
- Steven Cohen's Vertex Pharmaceuticals position peaked at $143M in Q1 2021.
- 1,797 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.